NCAPSULATE Trademark

Trademark Overview


On Tuesday, November 15, 2022, a trademark application was filed for NCAPSULATE with the United States Patent and Trademark Office. The USPTO has given the NCAPSULATE trademark a serial number of 79358678. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 24, 2024. This trademark is owned by Quantoom Biosciences, société anonyme. The NCAPSULATE trademark is filed in the Machinery Products and Computer & Software Products & Electrical & Scientific Products categories with the following description:

Scientific apparatus and instruments, namely, automated laboratory robots for handling, processing, analyzing and investigating DNA and RNA

Industrial robots used in the manufacture of pharmaceuticals, vaccines and therapeutics; pharmaceutical production machines for producing vaccines and mRNA-based therapeutics; machines for performing chain reactions for amplifying and replicating DNA and RNA, namely, industrial chemical reactors; disposable manufacturing components and assemblies for the biopharmaceutical industry, namely, single use disposable bioreactors for use in the manufacture of mRNA-based pharmaceuticals, vaccines and therapeutics
ncapsulate

General Information


Serial Number79358678
Word MarkNCAPSULATE
Filing DateTuesday, November 15, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2024

Trademark Statements


Goods and ServicesScientific apparatus and instruments, namely, automated laboratory robots for handling, processing, analyzing and investigating DNA and RNA
Goods and ServicesIndustrial robots used in the manufacture of pharmaceuticals, vaccines and therapeutics; pharmaceutical production machines for producing vaccines and mRNA-based therapeutics; machines for performing chain reactions for amplifying and replicating DNA and RNA, namely, industrial chemical reactors; disposable manufacturing components and assemblies for the biopharmaceutical industry, namely, single use disposable bioreactors for use in the manufacture of mRNA-based pharmaceuticals, vaccines and therapeutics

Classification Information


International Class007 - Machines and machine tools; motors and engines (except for land vehicles); machine coupling and transmission components (except for land vehicles); agricultural implements other than hand-operated; incubators for eggs.
US Class Codes013, 019, 021, 023, 024, 031, 034, 035
Class Status Code6 - Active
Class Status DateTuesday, December 27, 2022
Primary Code007
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, December 27, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQuantoom Biosciences, société anonyme
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Party NameQuantoom Biosciences, société anonyme
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Friday, December 23, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 31, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, May 31, 2023ASSIGNED TO EXAMINER
Friday, June 2, 2023NON-FINAL ACTION WRITTEN
Saturday, June 3, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 3, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 11, 2023REFUSAL PROCESSED BY MPU
Tuesday, July 11, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 1, 2023REFUSAL PROCESSED BY IB
Thursday, December 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 21, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, December 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, January 14, 2024NON-FINAL ACTION E-MAILED
Sunday, January 14, 2024NON-FINAL ACTION WRITTEN
Sunday, January 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 26, 2024REFUSAL PROCESSED BY IB
Friday, June 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, June 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, June 30, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, July 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 24, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED